Skip to main content

Adverum Biotechnologies, Inc.

ADVMDelisted Dec 9, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001501756

Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Adverum Biotechnologies, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of ADVM: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders11098−12
Shares70.0M65.9M−4.06M (−5.8%)
Value$151.2M$115.5M−$35.7M (−23.6%)

New holders (14)

Institutions that held Adverum Biotechnologies, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ADVM in Q4 2021
InstitutionSharesValue% of portfolio
EcoR1 Capital, LLC1,046,700$1.84M0.06%
Cowen and Company, LLC972,176$1.71M0.16%
Gsa Capital Partners LLP522,284$919.0K0.12%
Marshall Wace, LLP206,022$364.0K0.00%
Nomura Holdings Inc189,116$332.0K0.00%
Anson Funds Management LP81,824$144.0K0.02%
XTX Topco Ltd29,109$51.0K0.03%
Engineers Gate Manager LP25,769$45.0K0.00%
State of Wyoming14,936$26.0K0.01%
IPG Investment Advisors LLC10,000$18.0K0.00%
Capital Advisors, Ltd. LLC590$1.00K0.00%
Toronto Dominion Bank10$00.00%
Allworth Financial LP20$00.00%
Ellevest, Inc.120$00.00%

Sold out (26)

Institutions that held Adverum Biotechnologies, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.